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Tumor cells with tumorigenic potential are limited to
a small cell population known as cancer stem cells
(CSCs). CSCs yield both CSCs and non-CSCs, whereas
non-CSCs do not yield CSCs. CSCs have not been iden-
tified in any malignant lymphomas. Hodgkin lym-
phoma (HL) is a mostly B-cell neoplasm that can be
diagnosed by the presence of multinucleated (Reed-
Sternberg; RS) cells admixed with Hodgkin cells with
distinct nucleoli and various inflammatory cells.
Here, the tumorigenic potential of cells with a single
nucleus (S) and cells with multiple nuclei (M), which
may be equivalent to Hodgkin and RS cells, respec-
tively, was examined in HL cell lines L1236 and L428.
Cultures of single S cells yielded both S and M cells,
whereas M cell cultures yielded only M cells. When
either cultured in methylcellulose or inoculated into
NOD/SCID mice, the colony number and tumor size
were both larger in S than in M cells. Concentra-
tions of intracellular reactive oxygen species (ROS)
were at low levels in a portion of S cells that abun-
dantly expressed FoxO3a, a transcription factor
that regulates ROS-degrading enzymes. In clinical
samples of HL, FoxO3a was expressed in mononu-
clear Hodgkin cells but not in multinucleated RS
cells. These findings suggest that smaller cells or
Hodgkin cells that show low-ROS concentrations
and high FoxO3a expression levels might be candi-
dates for HL CSCs. (Am J Pathol 2010, 177:3081–3088;
DOI: 10.2353/ajpath.2010.100089)
Tumors consist of heterogenous cell populations derived
from a single clone. Recently, it has been demonstrated
that tumor cells with tumorigenic potential are limited to a
small population, called cancer-initiating cells or cancer
stem cells (CSCs), in several tumors, such as leukemia,
breast, brain, and colon cancers.1–8 CSCs yield both
CSCs and non-CSCs, whereas non-CSCs do not yield
CSCs.8 CSCs efficiently efflux antitumor chemicals and
degrade reactive oxygen species (ROS) that are related
to radiation-induced apoptosis.9 These characteristics
enable CSCs to be resistant to antitumor drugs and ra-
diation therapy. To date, CSCs have not been identified in
any kinds of malignant lymphomas.
Cell origin of Hodgkin lymphoma (HL) had been con-
troversial, but the studies based on molecular biology
revealed that HL is mostly a neoplasia of B lympho-
cyte.10,11 HL can be diagnosed by the presence of
multinucleated Reed-Sternberg (RS) cells and mononu-
clear Hodgkin cells intermingled with small lymphocytes
and various inflammatory cells. The RS cells are re-
garded as pathognomonic for HL. The RS and Hodgkin
cells share cell markers, such as CD15 and CD30, but the
proliferation potential in the RS cells was reported to be
lower than that of Hodgkin cells.12 To date, any markers that
differentiate Hodgkin cells from RS cells have not been
established. Here, a population showing CSC character
was examined in HL cell lines L1236 and L428.13,14 Tumor-
igenic potential and ROS-expelling ability were observed
mainly in a portion of small-sized mononuclear Hodgkin
cells. Large-sized RS-like cells appeared to be derived from
a portion of small-sized Hodgkin cells. Hodgkin cells pos-
sess properties suggestive of CSCs in HL.
Materials and Methods
Cell Line
Hodgkin lymphoma cell lines L1236 and L428 were pur-
chased from Deutsche Sammlung von Mikroorganismen and
Zellkulturen (Braunschweig, Germany). Cells were cultured in
RPMI 1640 (Sigma, St Louis, MO) supplemented with 10%
fetal calf serum (Nippon Bio-SupplyCenter, Tokyo, Japan).
Two Populations of Cells
A portion of cultured cells was cytospun on poly-L-lysine-
coated glass slides at 1500 rpm for 3minutes and stainedwith
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Giemsa solution. Cells with a single and multinucleus (more
than two nuclei) were named as S and M cells, respectively.
The mean size and SD of S and M cells are shown in Table 1.
As observed by Wolf et al,13 there was a limited number of
large-sized cells (Figure 1A), mostly with multinucleus.
Limiting Dilution
Cells were counted and diluted to the concentration at
one cell per 100 l of the medium. Then, 100 l was
cultured in each well of 96-well plates to determine the
replication capacity of a single cell. After 2 weeks, each
well was checked under a phase contrast microscopy to
determine the number and size of cells. At Giemsa stain-
ing, three types of wells were found; a well exclusively
containing S cells, M cells, and mixed S and M cells.
Because cells did not proliferate in several wells, the sum
of percentage of S, mixed, and M wells was not 100. The
proportion of multinucleated cells in S, mixed, and M
wells is shown in Table 2.
Immunofluorescence for CD15 and CD30
Cells were cytospun on poly-L-lysine-coated glass slides
at 1500 rpm for 3 minutes, fixed with 10% formalin for 10
minutes, and treated with 0.25% Triton X-100 solution for
10 minutes. After blocking with 5% bovine serum albumin
(Sigma), cells were incubated with anti-CD15 or anti-
CD30 antibody (DAKO A/S, Glostrup, Denmark). Then,
cells were treated with Alexa Fluor 488 anti-mouse IgG
(Invitrogen, Carlsbad, CA). As the negative control, stain-
ing was carried out in the absence of primary antibody.
Immunocytochemistry for Cell Cycle Proteins
(Ki-67 and Cyclin D2) and the Uptake of
Bromodeoxyuridine (BrdU)
Cells were cytospun, fixed with 10% formalin for 10 min-
utes, and treated with 0.25% Triton X-100 solution for
10 minutes. After treatment with peroxidase blocking so-
lution (DAKO), cells were incubated with anti–Ki-67
(DAKO) and anti–cyclin D2 (Abcam, Cambridge, UK)
antibodies. Then, cells were treated with ChemMate En-
Vision kit (DAKO). DAB (DAKO) was used as a chromo-
gen. As a negative control, staining was carried out in the
absence of primary antibody.
The uptake of BrdU was examined using BrdU in situ
detection kit (BD Biosciences, Franklin Lakes, NJ) ac-
cording to the manufacturer’s manual.
In Vitro Colony Formation Assay
The suspended 1000 cells were plated in culture dishes
with 1 ml of methylcellulose-containing DMEM supple-
mented with 15% FCS. The number of colonies was
counted on day14.
Table 1. Cell Size of S and M Cells in Hodgkin Lymphoma
Cell Lines
L1236 L428
S 29.6  7.8 m 21.0  4.8 m




Figure 1. Typical morphology of HL cell lines L1236 and L428. A: Giemsa
staining of original L1236 and L428 cells. B: Immunostaining for CD15 and
CD30.
Table 2. Proportion of Multinucleated Cells in S, Mixed,










S 10.2  1.5 NA 0.001
mixed 19.0  0.1 0.01 0.001
M 80.6  2.7 0.001 NA
NA, not applicable.
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Mice and Xenograft Transplantation
Six- to 8-week-old female nonobese diabetic/severe
combined immunodeficient (NOD/SCID) mice were pur-
chased from Charles River Laboratories Japan and kept
under specific pathogen-free conditions. Before xeno-
transplantation, the mice were deeply anesthetized. All
animal experiments were done according to the guideline
of Osaka University Animal Center and approved by the
institutional review board of committee of animal experi-
ments. In the previous study,13 2  107 cells were in-
jected for xenotransplantation. In this study, however,
total number of M cells was prepared at 2  103, be-
cause of low proliferative potential of M cells. Then, 2 
103 cells were used for xenotransplantation, and this was
enough to form tumors by S cells. S and M were sus-
pended in 0.2 ml of Matrigel (BD), and were injected
subcutaneously into the frank of left and right side of the
same animal, respectively. Tumor volume was estimated
using the formula: (width)2  (length)/2 according to the
report by Meyer-Siegler et al.15
Assay for Intracellular ROS Level
Cells were incubated with 10 mol/L of 5-(and-6)-chloro-
methyl-2,7-dichlorodihydrofluorescein diacetate, acetyl es-
ter (CM-H2DCFDA, Invitrogen) and 100 mol/L of H2O2 at
37°C for 20 minutes. Dead cells were stained with pro-
pidium iodide. ROS-high cells were stained in green and
dead cells in red. At least 200 S and M cells were exam-
ined, and the proportion of ROS-high viable cells was
counted.
Immunocytochemistry for FoxO3a and Catalase
FoxO3a and catalase expression was immunocytochemi-
cally examined with anti-FoxO3a antibody (Cell Signaling
Technology Inc, Beverly, MA) and anti-catalase antibody
(Sigma, St. Louis, MO). Cells were cytospun on poly-L-
lysine-coated glass slides at 1500 rpm for 3 minutes, fixed
with 10% formalin for 10 minutes and treated with 0.25%
Triton X-100 solution for 10 minutes. After treatment with
peroxidase blocking solution (DAKO), cells were incubated
with anti-FoxO3a and anti-catalase antibodies diluted at
250 and200, respectively. Then, cells were treated with
ChemMate EnVision kit (DAKO). DAB (DAKO) was used as
a chromogen. As the negative control, staining was carried
out in the absence of primary antibody. At least 200 S and
M cells were examined, and the proportion of FoxO3a ex-
pressing cells was counted.
Flow Cytometry and Real-Time Quantitative
Reverse Transcription–Polymerase Chain
Reaction (qRT-PCR)
Cells were stained with CM-H2DCFDA, and ROS-high
and ROS-low cells were sorted with FACSAria (Becton
Dickinson, Franklin Lakes, NJ). Total RNA was extracted
from sorted cells using RNeasy RNA extraction kit (Qia-
gen, Valencia, CA) according to the manufacturer’s pro-
tocol, and cDNA was synthesized using oligo (dT) prim-
ers and SuperScript III reverse transcriptase (Invitrogen).
The qRT-PCR was done with an ABI PRISM 7700 instru-
ment (Applied Biosystems, Foster City, CA) using Taq-
man probe/primer sets specific for human FoxO3a.
GAPDH was used as a reference for gene amplification
(Applied Biosystems).
Immunohistochemistry for FoxO3a
FoxO3a expression was immunocytochemically exam-
ined in clinical samples from 13 cases with Hodgkin
lymphoma with anti-FoxO3a antibody. Histological spec-
imens were fixed in 10% formalin and routinely pro-
cessed for paraffin-embedding. Sections were cut at 4
m thickness. After antigen retrieval with Pascal pressur-
ized heating chamber (DAKO), the sections were incu-
bated with anti-FoxO3a antibody diluted at 250. Then,
cells were treated with ChemMate EnVision kit (DAKO).
DAB was used as a chromogen. As the negative control,
staining was carried out in the absence of primary anti-
body. The study was approved by the ethical review
board of Graduate School of Medicine, Osaka University.
Two cases contained a limited number of RS cells. In
these cases, approximately 20 RS cells and the sur-
rounding Hodgkin cells were examined. In the remaining
cases, at least 50 RS cells and the surrounding Hodgkin
cells were examined.
Effect of Insulin and PI3K Inhibitor
To study the effect of insulin on the formation of M cells,
insulin was added to culture medium of S cells at a final
concentration of 0, 1, 3, 5, 10, and 50 g/ml. To study the
role of phosphatidylinositol-3 kinase (PI3K), PI3K inhibitor
LY294002 (Calbiochem, Darmstadt, Germany) was added
to cultures medium of S cells at a final concentration of 0,
1, 5, 10, 20, 50 mol/L and incubated at 37°C for 40
minutes. After that, insulin was added at a final concen-
tration of 0 and10 g/ml. After 7 days, at least 1000 cells
were cytospun, stained with Giemsa, and evaluated for
the percentage of M cells. Expression level of FoxO3a
was examined with immunocytochemistry.
Statistical Analysis
Statistical analyses were performed using Student’s t
tests. The values are shown as the mean  SE of at least
three experiments. The P values of less than 0.05 were
considered to be statistically significant.
Results
Single Cell Culture of HL Cell Lines
HL cell lines contained two population of cells, S andM cells
(Figure 1A). The mean size and SD of S and M cells were
shown in Table 1. Both S and M cells expressed CD15 and
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CD30 (Figure 1B). To evaluate the relation between S andM
cells, a single cell culture of L1236 was performed with
limiting dilution. After 14 days, the size of proliferating cells
in each well was checked with Giemsa staining and was
categorized as wells containing S cells, mixed S and M
cells, or M cells (Figure 2A). The number of wells with S,
mixed, and M cells per 100 wells was 18.1, 24.7, and 5.2
wells, respectively (mean of three independent experi-
ments, Figure 2B). Next, a single cell culture was repeated
with S and M cells. When a single cell culture of S cells was
done, number of wells with S, mixed, and M cells was 15.6,
26.0, and 3.1 wells per 100 wells. When a single cell culture
of M cells was done, number of wells with S, mixed, and M
cells was 0, 0, and 1.0 wells per 100 wells (Figure 2B).
These findings indicated that S cells yielded both S and M
cells. The M cells possessed a limited proliferative potential
and could not yield S cells. A limiting dilution was carried out
with another HL cell line L428. As observed in L1236, the
number of wells with M cells was lower than that of S and
mixed cells (Figure 2B).
Proliferative Activity of S and M Cells
Proportion of Ki-67–positive cells was higher in S than in
M cells of L1236 and L428 (Figure 3A). The proportion of
Figure 2. A limiting dilution of HL cell lines. A:When a single cell culture was done, wells containing exclusively S cells, mixed cell populations, or M cells were
obtained. The representative fields of L1236 were shown. B: Number of wells containing S, mixed, and M cells per 100 wells is shown. A single cell culture from
the original L1236 (left), from an S or M cell (middle), and a single cell culture from the original L428 culture (right). Because of the presence of wells without
any cellular proliferation, the sum of the well number was not 100.
Figure 3. Analysis of proliferative potential.
The proportion of Ki-67- (A) and cyclin D2- (B)
positive cells and BrdU-uptaking cells (C) was
compared between S and M cells of L1236 and
L428. The values are the mean  SE of three
experiments. *P  0.05 by the Student’s t-test.
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cyclin D2-positive cells (Figure 3B) and that of BrdU-
uptaking cells (Figure 3C) were also higher in S than in M
cells.
In Vitro Colony Formation Assay and
NOD/SCID Mouse Injection
To assess colony formation ability of S and M cells, both
types of cells were plated in methylcellulose-containing
DMEM supplemented with 15% FCS. Number of colonies
obtained from S cells was significantly higher than that
from M cells (Figure 4).
To examine the tumorigenicity in vivo, S and M cells
were injected into the left and right flank of NOD/SCID
mice. At 2 weeks after the injection, tumor mass was
found only in the injected site of S cells: the volume of
tumor was 215.4  122.7 mm2, 813.6  148.6 mm2, and
1510.6  430.3 mm2, at day 18, 22, and 26, respectively
(Figures 5, A–C). Tumor derived from S cells consisted of
both S and M cells (Figure 5D). No tumor was found in the
injected site of M cells throughout the observed period.
ROS Concentration in S and M Cells
CSCs are known to contain a lower level of ROS than
non-CSCs. Therefore, the level of ROS was examined in
L1236 cells after the addition of H2O2. Cells containing
high ROS showed green fluorescence after the incuba-
tion with CM-H2DCFDA. Although most M cells and a
majority of S cells were stained in green, approximately
10% of S cells showed a marginal green fluorescence,
indicating that the level of ROS was low in these S cells
(Figure 6).
Expression of FoxO3a
It is known that ROS level and FoxO3a level are inversely
correlated, because FoxO3a enhances the expression of
ROS-degradation enzymes, such as superoxide dimus-
tase and catalase. In fact, the expression level of FoxO3a
was higher in ROS-low cells than in ROS-high cells (Fig-
ure 7A). Hematopoietic stem cells express FoxO3a at a
high level, suggesting that CSCs of HL might show a high
FoxO3a expression as well. As expected, the expression
of FoxO3a was mostly confined to S cells, approximately
35% of S cells, suggesting that S cells contained a small
population expressing FoxO3a at a high level and ex-
cluding ROS (Figure 7B). The expression level of cata-
lase, whose expression was enhanced by FoxO3a, was
also high in approximately 30% of S cells (Figure 7C). In
Figure 4. In vitro colony formation assay. The number of colonies by culture
of S and M cells in methylcellulose are shown. The values are the mean  SE
of three experiments. *P  0.05 by the Student’s t-test.
Figure 5. Xenotransplantation of S and M cells of L1236 into NOD/SCID
mice. S and M cells were injected into the left (arrowhead) and right (arrow)
flanks of NOD/SCID mice. A: The volume of tumors derived from S and M cells.
The values are the mean  SE of three experiments. *P  0.05 by the Student’s
t-test. B: Tumor mass was found in the injected site of S cells (arrowhead) but
not of M cells (arrow). Tumor was found in dotted area. C: Resected tumor in the
injected site of S cells (left). No tumor was found in the injected site of M (right).D:
Resected tumor derived from S cells consisted of S and M cells (100).
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the clinical samples of HL, mononuclear Hodgkin cells
exclusively expressed FoxO3a, and multinucleated RS
cells did not (Figure 7D).
Effect of Insulin on the Formation of M Cells
Insulin is known to cause the degradation of FoxO3a
through PI3K pathway. To examine the role of FoxO3a for
ROS degradation, insulin was added to the culture me-
dium. The addition of insulin decreased the expression
level of FoxO3a in S cells (Figure 8A). Approximately 10%
of M cells expressed FoxO3a, but the addition of insulin
decreased its proportion to 3% (Figure 8A). As compared
to the culture without insulin, the proportion of M cells
increased from 2% to 8% when insulin was added (Figure
8B). This increase of M cells was diminished by the
addition of PI3K inhibitor LY294002 (Figure 8C). The ad-
dition of PI3K inhibitor alone without insulin did not affect
the proportion of M cells (Figure 8C). These findings
showed that the addition of insulin to S cells enhanced
the formation of M cells via PI3K pathway.
Discussion
HL is mostly a B-cell neoplasm which can be diagnosed
by the presence of multinucleated cells with distinct in-
clusion-like nucleoli (so-called diagnostic RS cells) ad-
mixed with Hodgkin cells with single nucleus in which
large nucleolus is discernible, small lymphoid cells, and
various inflammatory cells. Precise study based on the
analysis of immunoglobulin gene rearrangement and fu-
sion pattern of terminal repeats in Epstein-Barr virus
(EBV) for microdissected single cells from HL lesion re-
vealed the monoclonal nature, thus neoplastic B-cell in
nature, of the RS cells and Hodgkin cell.10,11 Here, the
tumorigenic potential of these two types of cells was
examined with HL cell line L1236 and L428. L1236 and
L428 are composed of two types of cells, S cells that
resembles to Hodgkin cells and M cells that resembles to
RS cells. S and M cells share a common immunopheno-
type; both express CD30 and CD15, but not CD20.13 EBV
DNA is not detectable in both S and M cells, because
L1236 and L428 cells are derived from the HL without
EBV infection.13,14
When the single S cell was cultured, cell populations
composed of S, M, and mixed of both were developed. In
contrast, M cells hardly proliferated. Among 100 wells of
a single cell culture of M cells, only one well yielded
Figure 6. ROS concentration in S and M cells. ROS-high cells stained green
and dead cells stained red. ROS-low viable cells are indicated by arrows.
Figure 7. Expression of FoxO3a and catalase. A: Real-time quantitative
RT-PCR for FoxO3a in ROS-low and -high L1236 cells. The values are the
mean  SE of three experiments. *P  0.05 by the Student’s t-test. Immu-
nocytochemistry of FoxO3a (B) and catalase (C) in L1236 cells (400). D:
Immunohistochemistry of FoxO3a in clinical samples of HL (400).
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detectable cell population composing exclusively M
cells. These findings indicated that a single cell culture of
S cells yielded both S and M cells. Whereas, M cells
showed a limited proliferative potential and yielded M
cells but not S cells. The proportion of Ki-67 or cyclin
D2-positve, and BrdU-uptaking cells was generally
higher in S cells than in M cells of both L1236 and L428:
approximately 30% and 10% in Ki-67, 7% and 0% in
cyclin D2, and 10% and 0% in BrdU in L1236; 100% and
80% in Ki-67, 9% and 2% in cyclin D2, and 40% and 10%
in BrdU in L428, respectively. (The former value is S and
the latter is M.) These findings showed the limited prolif-
erative potential of M cells. CSCs are known to yield both
CSC and non-CSC, whereas non-CSCs yield only non-
CSCs.8 Therefore cells with CSC character appeared to
be present among S cells. CSCs possess a strong tumor-
igenic ability when cultured in semisolid condition or
transplanted into NOD/SCID mice. In methycellulose cul-
ture and inoculation into NOD/SCID mice, the number of
colonies and the size of tumors were larger in S cells than
in M cells. These findings supported the above-men-
tioned notion that CSCs were present among S cells.
Wolf et al13 reported the xenotransplantation of 2 107
of L1236 cells into Scid mice: tumor was formed at 6
weeks after transplantation, reached the size of 0.5 to 1
cm in diameter, then regressed completely. Whereas the
tumor was not spontaneously regressed even after
reaching the diameter of approximately 2 cm at up to 4
weeks in present study. This might be partly explained
that the injected cells were not the original L1236 but the
selected S cell population. In the current study, 2  103
S cells were enough to form tumors at 2 week after
transplantation, suggesting that the S cells selected from
mixed population possessed more tumorigenic potential
than nonselected L1236 cells. Higher proportion of Ki-67,
cyclin D2–positive, and BrdU-uptaking cells among S
cells than M cells found in the present study explained
more tumorigenic potential of S cells than M cells.
Next, we further characterized the S cells. Recently,
CSCs have been reported to possess the ability to keep
the concentration of ROS at a low level.9 Then, H2O2 was
added to L1236, and the concentration of ROS in each
cell type was measured with CM-H2DCFDA. M cells and
most of S cells showed high ROS concentration in the
presence of H2O2, but the concentration was at a low
level in a portion of S cells. FoxO3a is a transcription
factor regulating the expression of ROS-degrading en-
zymes, such as catalase.16–19 A portion of S cells
exclusively expressed FoxO3a and catalase, whereas
M cells did not. In the clinical samples of HL, FoxO3a
was expressed mainly in the mononuclear Hodgkin
cells but not in the multinucleated RS cells. These
findings suggested that approximately 10% of S cells
keeping ROS concentration at a low level and showing
high FoxO3a and catalase expression might be a can-
didate for CSCs of HL.
Recently, Jones reported the circulating clonotypic B
cell population with small sizes and high expression of
aldehyde dehydrogenase and CD27 in HL patients.20
This population efficiently formed colonies in vitro. These
findings were similar to those found in the S cells popu-
lation reported in our study. Further studies will clarify the
relation between these two populations.
Wolf et al13 described that L1236 may not be a repre-
sentative HL cell line due to numerous chromosomal
aberrations and atypical karyotype for HL. Then, another
HL cell line L428, which shows fewer chromosomal ab-
errations than L1236, was examined in the present study,
and the similar results were obtained.21,22 Although the
limited proliferative potential of M cells might be due to
the culture system, we considered that S cells possessed
tumorigenic potential as compared to M cells based on
the in vivo xenotransplantation experiment, the distinct
Figure 8. Effect of insulin on the formation of M cells. A: Change of
proportion of FoxO3a-expressing L1236 cells by the addition of insulin. B:
Proportion of M cells among L1236 cultured with insulin. C: LY294002
inhibited the formation of M cells. The values are the mean  SE of three
experiments. *P  0.05 by the Student’s t-test.
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higher expression level of Ki-67 and cyclin D2, and BrdU
uptake in S than in M cells.
It is reported that activation of PI3K pathway sup-
presses the FoxO3a expression.23 It is known that many
reagents, including insulin, activate PI3K.23,24 If FoxO3a
plays a role for maintenance of CSCs in HL, the addition
of insulin might result in decrease of number of tumori-
genic S cells and increase of nontumorigenic M cells. As
expected, the addition of insulin increased the proportion
of M cells, and this was inhibited by LY294002, an inhib-
itor for PI3K pathway. Yilmaz et al and Zhang et al re-
ported that the hematopoitetic stem cells are diminished
when phosphatase and tensin homolog (PTEN), an an-
tagonist against PI3K, is knocked-out.25,26 It is suggested
that the activation of PI3K pathway appeared to decrease
the stem cell activity not only in hematopoietic system but
also in HL.
Taken together, among morphologically distinctive HL
neoplastic cells, a portion of single-nucleated cells was
tumorigenic and possess CSC-like characters.
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